BETHESDA, MD—Where do you find resiliency as a healer and a soldier? As the role of combat medics becomes more and more important to the increasing survival rate of combat casualties, that is a question that military psychiatrists are asking.

BETHESDA, MD—It was two years ago that Ira Katz, MD, PhD, then chief of VA’s mental health services, told researchers at the VISN 20 Mental Illness Research, Education, and Clinical Center (MIRECC) in Portland, OR, that they should begin focusing some of their research on TBI.

BETHESDA, MD—Women comprise nearly 20-percent of the military. Many women, like their male counterparts, return from combat traumatized by the events they experienced.

WASHINGTON, DC—The development of a new strategy is in the works to support Native Americans who find themselves in the hospital emergency department for alcohol related injuries.

WASHINGTON, DC—While the overall negative health effects of smoking have been common knowledge for many years, a newly-released Surgeon General’s report goes into unprecedented detail on how tobacco causes disease at a biological and behavioral level.

BETHESDA, MD—NIH is examining the possibility of creating a single institute for substance use, abuse, and addiction research.

WASHINGTON, DC—Progress has been made in increasing the number of Americans tested for HIV.

BETHESDA, MD—“Combat injury is not an event. It’s a process.” Those words, spoken by Stephen Cozza, MD, associate director of the USUHS Center for the Study of Traumatic Stress, could have been taken as the central theme of DCoE’s Trauma Spectrum Conference held last month on the campus of NIH. The conference has focused attention for the last three years on the effects of combat trauma not only on the soldier, but also on their spouses, children, friends, and society as a whole.

Thomas Kosten has been fascinated by the mechanisms of addiction since his first year as a medical student. While working through the MD/PhD program at Cornell Medical School, Kosten became interested in the field of opioid dependence, working in the methadone program.

Becaplermin Use and Cancer Risk in Veterans with Diabetes

Objective: This is an observational study of VA patients with diabetes. REGRANEX® (becaplermin) is topical medication used to treat lower extremity diabetic neuropathic ulcers.